UCL Discovery Stage
UCL home » Library Services » Electronic resources » UCL Discovery Stage

Clinical neuroimaging in intracerebral haemorrhage related to cerebral small vessel disease: contemporary practice and emerging concept

Goeldlin, Martina; Stewart, Catriona; Radojewski, Piotr; Wiest, Roland; Seiffge, David; Werring, David J; (2022) Clinical neuroimaging in intracerebral haemorrhage related to cerebral small vessel disease: contemporary practice and emerging concept. Expert Review of Neurotherapeutics , 22 (7) pp. 579-594. 10.1080/14737175.2022.2104157. Green open access

[thumbnail of Werring_Clinical neuroimaging in intracerebral haemorrhage related to cerebral small vessel disease_AAM.pdf]
Preview
Text
Werring_Clinical neuroimaging in intracerebral haemorrhage related to cerebral small vessel disease_AAM.pdf

Download (542kB) | Preview

Abstract

INTRODUCTION: About 80% of all non-traumatic intracerebral haemorrhage (ICH) are caused by the sporadic cerebral small vessel diseases deep perforator arteriopathy (DPA, also termed hypertensive arteriopathy or arteriolosclerosis) and cerebral amyloid angiopathy (CAA), though these frequently co-exist in older people. Contemporary neuroimaging (MRI and CT) detects an increasing spectrum of haemorrhagic and non-haemorrhagic imaging biomarkers of small vessel disease which may identify the underlying arteriopathies. AREAS COVERED: We discuss biomarkers for cerebral small vessel disease subtypes in ICH, and explore their implications for clinical practice and research. EXPERT OPINION: ICH is not a single disease, but results from a defined range of vascular pathologies with important implications for prognosis and treatment. The terms "primary" and "hypertensive" ICH are poorly defined and should be avoided, as they encourage incomplete investigation and classification. Imaging-based criteria for CAA will show improved diagnostic accuracy, but specific imaging biomarkers of DPA are needed. Ultra-high-field 7T-MRI using structural and quantitative MRI may provide further insights into mechanisms and pathophysiology of small vessel disease. We expect neuroimaging biomarkers and classifications to allow personalized treatments (e.g. antithrombotic drugs) in clinical practice and to improve patient selection and monitoring in trials of targeted therapies directed at the underlying arteriopathies.

Type: Article
Title: Clinical neuroimaging in intracerebral haemorrhage related to cerebral small vessel disease: contemporary practice and emerging concept
Location: England
Open access status: An open access version is available from UCL Discovery
DOI: 10.1080/14737175.2022.2104157
Publisher version: https://doi.org/10.1080/14737175.2022.2104157
Language: English
Additional information: This version is the author accepted manuscript. For information on re-use, please refer to the publisher's terms and conditions.
Keywords: CT, Intracerebral hemorrhage, MRI, amyloid-related inflammation, cerebral amyloid angiopathy, deep perforator arteriopathy, emerging strategies, hereditary small vessel disease, neuroimaging, small vessel diseases
UCL classification: UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology > Brain Repair and Rehabilitation
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology
URI: https://discovery-pp.ucl.ac.uk/id/eprint/10153131
Downloads since deposit
1,292Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item